DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Safety of Epidural Fentanyl and Adrenalin During Childbirth

Information source: Rikshospitalet-Radiumhospitalet HF
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pregnancy; Pain

Intervention: adrenalin (Drug); placebo (Drug)

Phase: Phase 4

Status: Not yet recruiting

Sponsored by: Rikshospitalet-Radiumhospitalet HF

Official(s) and/or principal investigator(s):
Harald Breivik, PhD MD, Study Director, Affiliation: Division of Anaesthesia and Intensive Care Medicine, Rikshospitalet University Hospital, Oslo, Norway

Overall contact:
Leiv Arne Rosseland, PhD MD, Phone: 47-2307-3700, Email: l.a.rosseland@medisin.uio.no

Summary

Investigation of pharmacokinetic effects of combining fentanyl and adrenalin in the epidural solution given to women in childbirth

Clinical Details

Official title: Pharmacokinetic Interaction Effects of Combined Fentanyl and Adrenalin in Epidural Analgesia During Child Birth

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Plasma concentration of fentanyl

Secondary outcome: length of active labor

Detailed description: Healthy women with indication for labor epidural at the Labor Clinic, Rikshospitalet University Hospital, may be included. A randomized, placebocontrolled, double blind,comparison of epidural with and without adrenalin. Outcome: Length of birth, quality of pain relief, total amount of epidural solution injected, and plasma concentration of fentanyl.

Eligibility

Minimum age: 18 Years. Maximum age: 40 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Pregnant women at term in active labor

Exclusion Criteria:

- age below 18 years

- BMI > 40

- drug hypersensitivity

Locations and Contacts

Leiv Arne Rosseland, PhD MD, Phone: 47-2307-3700, Email: l.a.rosseland@medisin.uio.no

Division of Anaesthesiology and Intensive Care Medicine, Rikshospitalet University Hospital, Oslo 0027, Norway
Additional Information

Starting date: August 2008
Ending date: June 2010
Last updated: May 23, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009